Yükleniyor... / Loading...
This study assesses cognitive functioning and quality of life in patients who have been treated for primary central nervous system lymphoma. English-speaking patients who had been diagnosed with and treated for PCNSL and whose disease was in remission at the time of testing could take part. This was a study without a phase and has been completed.
The summary above is a plain-language rendering of the official record. The original English title is shown for reference.
Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.
Inclusion Criteria: * Diagnosis of and treatment for PCNSL * Disease in remission at the time of testing, as defined by negative MRI and/or CSF cytology, and ocular exam if initially positive * English speaking Exclusion Criteria: * patients who are medically unstable * patients with severe, decompensated psychiatric disorders * patients with a pre-existing neurological condition other than the designated illness (e. g., head trauma)